2764 Preliminary results of the phase I/IIa dose finding trial of a folate binding protein vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence. (September 2015) - Greene, J.M.; Schneble, E.J.; Berry, J.S.; Trappey, A.F.; Clifton, G.T.; Darcy, K.; Elkas, J.C.; Hamilton, C.A.; Maxwell, G.L.; Peoples, G.E.